213 related articles for article (PubMed ID: 23560732)
21. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.
Neal MD; Alverdy JC; Hall DE; Simmons RL; Zuckerbraun BS
Ann Surg; 2011 Sep; 254(3):423-7; discussion 427-9. PubMed ID: 21865943
[TBL] [Abstract][Full Text] [Related]
22. Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
Apisarnthanarak A; Khoury H; Reinus WR; Crippin JS; Mundy LM
Am J Med; 2002 Mar; 112(4):328-9. PubMed ID: 11893379
[No Abstract] [Full Text] [Related]
23. Intracolonic Vancomycin Through Laprascopic Appendicostomy for Treatment of Severe Clostridium difficile Colitis Does Not Get Systemic Absorption.
Alhazmi L; Almeshal N; Assaly R
Am J Ther; 2017; 24(5):e616. PubMed ID: 28301334
[No Abstract] [Full Text] [Related]
24. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality.
Sailhamer EA; Carson K; Chang Y; Zacharias N; Spaniolas K; Tabbara M; Alam HB; DeMoya MA; Velmahos GC
Arch Surg; 2009 May; 144(5):433-9; discussion 439-40. PubMed ID: 19451485
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile infection worsens the prognosis of ulcerative colitis.
Negrón ME; Barkema HW; Rioux K; De Buck J; Checkley S; Proulx MC; Frolkis A; Beck PL; Dieleman LA; Panaccione R; Ghosh S; Kaplan GG
Can J Gastroenterol Hepatol; 2014; 28(7):373-80. PubMed ID: 25157528
[TBL] [Abstract][Full Text] [Related]
26. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.
Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; Miera IS; Chowers Y; Moran GW;
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):981-7. PubMed ID: 19523534
[TBL] [Abstract][Full Text] [Related]
27. The outcome of surgery in fulminant Clostridium difficile colitis.
Koss K; Clark MA; Sanders DS; Morton D; Keighley MR; Goh J
Colorectal Dis; 2006 Feb; 8(2):149-54. PubMed ID: 16412077
[TBL] [Abstract][Full Text] [Related]
28. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
Chihara S; Shimizu R; Furukata S; Hoshino K
Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile bacteremia, Taiwan.
Lee NY; Huang YT; Hsueh PR; Ko WC
Emerg Infect Dis; 2010 Aug; 16(8):1204-10. PubMed ID: 20678312
[TBL] [Abstract][Full Text] [Related]
30. Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon.
Causey MW; Walker A; Cummings M; Johnson EK; Maykel JA; Steele S
Colorectal Dis; 2014 Feb; 16(2):O71-4. PubMed ID: 24134562
[TBL] [Abstract][Full Text] [Related]
31. Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
Aradhyula S; Manian FA; Hafidh SA; Bhutto SS; Alpert MA
South Med J; 2006 May; 99(5):518-20. PubMed ID: 16711316
[TBL] [Abstract][Full Text] [Related]
32. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis.
Byrn JC; Maun DC; Gingold DS; Baril DT; Ozao JJ; Divino CM
Arch Surg; 2008 Feb; 143(2):150-4; discussion 155. PubMed ID: 18283139
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.
Jodorkovsky D; Young Y; Abreu MT
Dig Dis Sci; 2010 Feb; 55(2):415-20. PubMed ID: 19255850
[TBL] [Abstract][Full Text] [Related]
34. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
[TBL] [Abstract][Full Text] [Related]
35. The impact of Clostridium difficile on paediatric surgical practice: a systematic review.
Mc Laughlin D; Friedmacher F; Puri P
Pediatr Surg Int; 2014 Aug; 30(8):853-9. PubMed ID: 25008231
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
de Lalla F; Nicolin R; Rinaldi E; Scarpellini P; Rigoli R; Manfrin V; Tramarin A
Antimicrob Agents Chemother; 1992 Oct; 36(10):2192-6. PubMed ID: 1444298
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
O'Donnell JN; Novak GM; Bratek BR; Singh G; Duru OO; Mitchell CL; Roddy KM; Bidell MR
Int J Antimicrob Agents; 2021 Apr; 57(4):106311. PubMed ID: 33621602
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of patients with fulminant Clostridium difficile colitis.
Miller AT; Tabrizian P; Greenstein AJ; Dikman A; Byrn J; Divino C
J Gastrointest Surg; 2009 May; 13(5):956-9. PubMed ID: 19224298
[TBL] [Abstract][Full Text] [Related]
39. Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
Mizumura N; Demura K; Kawasaki M; Okumura S; Toyoda S; Imagawa A; Ogawa M; Ohba K; Kameyama M
Intern Med; 2015; 54(12):1559-62. PubMed ID: 26073250
[TBL] [Abstract][Full Text] [Related]
40. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.
Dallal RM; Harbrecht BG; Boujoukas AJ; Sirio CA; Farkas LM; Lee KK; Simmons RL
Ann Surg; 2002 Mar; 235(3):363-72. PubMed ID: 11882758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]